Candidate VY1706 demonstrates significant reductions of tau at low doses in NHP study; IND and CTA filings anticipated in ...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ: EPRX) (TSX: EPRX), a clinical-stage biotechnology ...

Belite Bio's, Tinlarebant, targets eye diseases STGD1 and GA, showing promising results but with delayed phase 3 trial data.

KALAMAZOO, Mich. — Those who are recovering from addiction now have a new lifeline in Kalamazoo. Reach Sober Living has just ...

Merck's (MRK) new injectable version of Keytruda aims to overcome regulatory hurdles and market challenges, offering a more ...

Findings suggest semaglutide and other GLP-1 agonists may significantly reduce alcohol use disorder hospitalizations, ...

The relatively new and less detectable product’s increasing prevalence among youth underscores an urgent need for informed ...

In the past, when someone was sentenced to substance-use-disorder (SUD) treatment in lieu of jail time in connection with ...

Public health groups are challenging Roche's attempt to block a generic version of its expensive Spinal Muscular Atrophy drug, Risdiplam. They argue that Roche's patent infringement lawsuit ...

The origins of autoimmune diseases like it are often mysterious, and an immune system that sees the body it inhabits as an ...

SkyTrain’s oldest cars, dating back to the 1980s and early 1990s, are now officially entering retirement, and the hope now is that some of these cars can be repurposed and relocated to commemorate ...